InsiderTrades.com logo
“Buffett Indicator” Predicts 62% Stock Market Crash
From Behind the Markets   |   Ad
The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.
Take these 4 steps to protect your retirement here >>>

SAR Insider Trading

Insider Ownership Percentage: 5.02%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £28,742.82

Sareum Insider Trading History Chart

This chart shows the insider buying and selling history at Sareum by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sareum Share Price & Price History

Current Price: GBX 25.10
Price Change: ▲ Price Increase of +1.6 (6.81%)
As of 10/30/2024 01:05 PM ET

This chart shows the closing price history over time for SAR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
From Paradigm Press   |   Ad
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
Click here to see it because it’s a SHOCKER…

Sareum Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2023John C ReaderInsiderSell50,426GBX 57£28,742.82
9/4/2023Clive BirchInsiderBuy2,479GBX 82£2,032.78
12/28/2022Stephen ParkerInsiderBuy19,972GBX 78£15,578.16
11/23/2021Stephen ParkerInsiderBuy277,777GBX 4£11,111.08
See Full Table
The real reason Elon is fully endorsing Trump
From Porter & Company   |   Ad
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
Watch this new documentary and you’ll discover what Elon knows,

SEC Filings (Institutional Ownership Changes) for Sareum (LON:SAR)

Sareum logo
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases. Its also developing SDC-1802, a TYK2/JAK1 inhibitor, which is in preclinical stage for cancerandcancer-immunotherapy applications; and SRA737, a clinical-stage, oral, selective Checkpoint kinase 1 (Chk1) inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
Read More on Sareum

Today's Range

Now: GBX 25.10
Low: 23.30
High: 26

50 Day Range

MA: GBX 27.36
Low: 23.41
High: 31

52 Week Range

Now: GBX 25.10
Low: 10
High: 78

Volume

555,319 shs

Average Volume

726,900 shs

Market Capitalization

£27.10 million

P/E Ratio

N/A

Dividend Yield

1.10%

Beta

N/A

Who are the company insiders with the largest holdings of Sareum?

Sareum's top insider investors include:
  1. Clive Birch (Insider)
  2. John C Reader (Insider)
  3. Stephen Parker (Insider)
Learn More about top insider investors at Sareum.
“Buffett Indicator” Predicts 62% Stock Market Crash
From Behind the Markets   |   Ad
The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.
Take these 4 steps to protect your retirement here >>>